Maynard Um
-
-
-
-
-
-
-
SkinMedica launches advisory board and expands R&D lab in Irvine
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Abbvie (ABBV)
-
-
-
-
-
-
-
Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald after Analyst Call
-
-
-
-
-
-
-
AbbVie to present blood cancer data at EHA 2026
-
-
-
-
-
-
-
AbbVie presents inflammatory bowel disease data at medical conference
-
-
-
-
-
-
-
AbbVie submits FDA application for SKYRIZI subcutaneous dosing
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $249 at Guggenheim
-
426,817 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

